Cargando…

MM2S: personalized diagnosis of medulloblastoma patients and model systems

BACKGROUND: Medulloblastoma (MB) is a highly malignant and heterogeneous brain tumour that is the most common cause of cancer-related deaths in children. Increasing availability of genomic data over the last decade had resulted in improvement of human subtype classification methods, and the parallel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gendoo, Deena M.A., Haibe-Kains, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827218/
https://www.ncbi.nlm.nih.gov/pubmed/27069505
http://dx.doi.org/10.1186/s13029-016-0053-y
_version_ 1782426441483288576
author Gendoo, Deena M.A.
Haibe-Kains, Benjamin
author_facet Gendoo, Deena M.A.
Haibe-Kains, Benjamin
author_sort Gendoo, Deena M.A.
collection PubMed
description BACKGROUND: Medulloblastoma (MB) is a highly malignant and heterogeneous brain tumour that is the most common cause of cancer-related deaths in children. Increasing availability of genomic data over the last decade had resulted in improvement of human subtype classification methods, and the parallel development of MB mouse models towards identification of subtype-specific disease origins and signaling pathways. Despite these advances, MB classification schemes remained inadequate for personalized prediction of MB subtypes for individual patient samples and across model systems. To address this issue, we developed the Medullo-Model to Subtypes (MM2S) classifier, a new method enabling classification of individual gene expression profiles from MB samples (patient samples, mouse models, and cell lines) against well-established molecular subtypes [Genomics 106:96-106, 2015]. We demonstrated the accuracy and flexibility of MM2S in the largest meta-analysis of human patients and mouse models to date. Here, we present a new functional package that provides an easy-to-use and fully documented implementation of the MM2S method, with additional functionalities that allow users to obtain graphical and tabular summaries of MB subtype predictions for single samples and across sample replicates. The flexibility of the MM2S package promotes incorporation of MB predictions into large Medulloblastoma-driven analysis pipelines, making this tool suitable for use by researchers. RESULTS: The MM2S package is applied in two case studies involving human primary patient samples, as well as sample replicates of the GTML mouse model. We highlight functions that are of use for species-specific MB classification, across individual samples and sample replicates. We emphasize on the range of functions that can be used to derive both singular and meta-centric views of MB predictions, across samples and across MB subtypes. CONCLUSIONS: Our MM2S package can be used to generate predictions without having to rely on an external web server or additional sources. Our open-source package facilitates and extends the MM2S algorithm in diverse computational and bioinformatics contexts. The package is available on CRAN, at the following URL: https://cran.r-project.org/web/packages/MM2S/, as well as on Github at the following URLs: https://github.com/DGendoo and https://github.com/bhklab. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13029-016-0053-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4827218
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48272182016-04-12 MM2S: personalized diagnosis of medulloblastoma patients and model systems Gendoo, Deena M.A. Haibe-Kains, Benjamin Source Code Biol Med Software BACKGROUND: Medulloblastoma (MB) is a highly malignant and heterogeneous brain tumour that is the most common cause of cancer-related deaths in children. Increasing availability of genomic data over the last decade had resulted in improvement of human subtype classification methods, and the parallel development of MB mouse models towards identification of subtype-specific disease origins and signaling pathways. Despite these advances, MB classification schemes remained inadequate for personalized prediction of MB subtypes for individual patient samples and across model systems. To address this issue, we developed the Medullo-Model to Subtypes (MM2S) classifier, a new method enabling classification of individual gene expression profiles from MB samples (patient samples, mouse models, and cell lines) against well-established molecular subtypes [Genomics 106:96-106, 2015]. We demonstrated the accuracy and flexibility of MM2S in the largest meta-analysis of human patients and mouse models to date. Here, we present a new functional package that provides an easy-to-use and fully documented implementation of the MM2S method, with additional functionalities that allow users to obtain graphical and tabular summaries of MB subtype predictions for single samples and across sample replicates. The flexibility of the MM2S package promotes incorporation of MB predictions into large Medulloblastoma-driven analysis pipelines, making this tool suitable for use by researchers. RESULTS: The MM2S package is applied in two case studies involving human primary patient samples, as well as sample replicates of the GTML mouse model. We highlight functions that are of use for species-specific MB classification, across individual samples and sample replicates. We emphasize on the range of functions that can be used to derive both singular and meta-centric views of MB predictions, across samples and across MB subtypes. CONCLUSIONS: Our MM2S package can be used to generate predictions without having to rely on an external web server or additional sources. Our open-source package facilitates and extends the MM2S algorithm in diverse computational and bioinformatics contexts. The package is available on CRAN, at the following URL: https://cran.r-project.org/web/packages/MM2S/, as well as on Github at the following URLs: https://github.com/DGendoo and https://github.com/bhklab. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13029-016-0053-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-11 /pmc/articles/PMC4827218/ /pubmed/27069505 http://dx.doi.org/10.1186/s13029-016-0053-y Text en © Gendoo and Haibe-Kains. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Software
Gendoo, Deena M.A.
Haibe-Kains, Benjamin
MM2S: personalized diagnosis of medulloblastoma patients and model systems
title MM2S: personalized diagnosis of medulloblastoma patients and model systems
title_full MM2S: personalized diagnosis of medulloblastoma patients and model systems
title_fullStr MM2S: personalized diagnosis of medulloblastoma patients and model systems
title_full_unstemmed MM2S: personalized diagnosis of medulloblastoma patients and model systems
title_short MM2S: personalized diagnosis of medulloblastoma patients and model systems
title_sort mm2s: personalized diagnosis of medulloblastoma patients and model systems
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827218/
https://www.ncbi.nlm.nih.gov/pubmed/27069505
http://dx.doi.org/10.1186/s13029-016-0053-y
work_keys_str_mv AT gendoodeenama mm2spersonalizeddiagnosisofmedulloblastomapatientsandmodelsystems
AT haibekainsbenjamin mm2spersonalizeddiagnosisofmedulloblastomapatientsandmodelsystems